Dermatomyositis is a rare inflammatory disease ... Hence, Dr Himanshi Chaudhary insisted that early diagnosis and treatment are crucial in managing JDM and preventing complications such as ...
Since patients with refractory Dermatomyositis (DM) may not respond to existing treatment options, there remains an unmet medical need for more therapeutic alternatives. There are now several drug ...
Received FDA orphan drug designation for the treatment of dermatomyositis in April 2017. Received FDA approval for the treatment of dermatomyositis in adults in July 2021. In ITP, Octagam 10% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback